Furosemide Administration Guidelines
Patient Monitoring and Assessment
- The American Association for the Study of Liver Diseases recommends daily monitoring of weight with a target weight loss of ≤0.5 kg/day in patients without edema, and also monitoring of vital signs such as blood pressure and heart rate 1
- Laboratory tests, including serum electrolytes, BUN, creatinine, serum calcium, magnesium, and urine and blood glucose in diabetic patients, should be performed to assess patient response and potential adverse effects 1
Indications and Contraindications
- The American Heart Association recommends combination with nitrates for moderate-to-severe pulmonary edema rather than aggressive diuretic monotherapy in heart failure patients 2
- The European Association for the Study of the Liver recommends aldosterone antagonists as the mainstay of diuretic treatment for liver cirrhosis, with furosemide added as combination therapy 1
- Furosemide should not be used in patients with hepatic encephalopathy, hyponatremia below 120 mmol/L despite water restriction, acute kidney injury, or lack of response with appropriate low-salt diet 1
Dosage and Administration
- The initial dose of furosemide for edema associated with congestive heart failure, liver cirrhosis, or renal disease is 20-80 mg as a single dose, with maintenance doses repeated after 6-8 hours or increased by 20-40 mg increments 1
- The maximum dose of furosemide is up to 600 mg/day in severe edematous states 1
Adverse Effects and Interactions
- The American College of Emergency Physicians reports that transient worsening of hemodynamics, including increased systemic vascular resistance and left ventricular filling pressures, can occur 1-2 hours after furosemide administration 2
- Furosemide can cause ototoxicity, especially with rapid IV administration or when combined with other ototoxic drugs, and can also precipitate gout and worsen diabetes control 2